InsidersTradesSigma
Lytix Biopharma ASA Stock: price and management transactions · Norway · Oslo Børs
Follow the Lytix Biopharma ASA share price and the full insider trade history of the company, a listed equity based in Norway. Shares are quoted on NO NO, under the authority of Oslo Børs. Operating in the Healthcare & Pharma sector, Lytix Biopharma ASA has recorded 15 insider filings. Market capitalisation: €744.4m. The latest transaction was filed on 9 April 2026 (Option grant). Among the most active insiders: Norwegian Securities Trading Act.. Every trade is openly available.
15
Insider Decl.
0
Thresholds
€473,332
7 ops.
Buy Volume
·
0 ops.
Sell Volume
10Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 April 2026
Declarations15 total
OptionMERKOSLO:670327
ShareMERKOSLO:663387
10,000 shares@ NOK 9.9984100.0% of flowShareMERKOSLO:661716
Ideal exit: 7 Sept 2026 (T+270)
OptionMERKOSLO:654449
ShareMERKOSLO:635698
ShareMERKOSLO:634985
ShareMERKOSLO:634909
@ €0.0085ShareMERKOSLO:617032
724,448 shares@ NOK 5.24100.0% of flowShareMERKOSLO:616907
OptionMERKOSLO:587883
33,519 shares@ NOK 8.565621.7% of flowShareMERKOSLO:570389
Ideal exit: 29 May 2023 (T+270)
125,000 shares@ NOK 7.971478.3% of flowShareMERKOSLO:569902
Ideal exit: 24 May 2023 (T+270)
13,000 shares@ NOK 7.7274100.0% of flowShareMERKOSLO:569869
Ideal exit: 23 May 2023 (T+270)
15 of 15 declarations
About Lytix Biopharma ASA
Lytix Biopharma ASA is a biopharmaceutical company focused on developing immuno-oncology treatments. It is listed on the XOSL market.
